Large arrow graphic

Paul Mignon and inVentiv Health Receive 2013 Award of Hope for Corporate Leadership from Rutgers Cancer Institute of New Jersey

Mignon, President of inVentiv Selling Solutions, Recognized for Commitment to Serving People with Cancer in his Home State of New Jersey

BURLINGTON, MASS. – November 1, 2013 – inVentiv Health, offering best-in-class clinical, commercial and consulting services, announced today that the company and a dedicated inVentiv executive have been awarded the 2013 Award of Hope for Corporate Leadership from Rutgers Cancer Institute of New Jersey.

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey is dedicated to improving the prevention, detection, treatment, and care of patients with cancer, through the transformation of laboratory discoveries into clinical practice. It’s Award of Hope has been given over the last 16 years to recognize those who have demonstrated untiring leadership and a deep commitment to serving the needs of people with cancer.

Mignon, President of inVentiv Health Selling Solutions, was introduced to the Cancer Institute in 2001 when a close friend was diagnosed with cancer. Witnessing his friend’s battle first-hand inspired Mignon to get involved. Over time, he became an ambassador for the Cancer Institute, personally and professionally, helping to raise funds that enabled the growth of the Institute into one of the nation’s leading cancer centers.

He established a partnership between the Institute and inVentiv, recognizing that both organizations in different ways shared an interest in delivering extraordinary outcomes to patients. inVentiv has been a regular contributor to the Institute’s work, while the Institute has helped inVentiv by providing cancer education for employees. The partnership has endured for nearly a decade.

“We are proud of Paul and grateful to him for suggesting ways in which we could partner in supporting one of New Jersey’s most distinguished health care institutions,” said Paul Meister, CEO of inVentiv Health. “We are very honored to be recognized in this way.”

Mignon also has volunteered as a Trustee of the Cancer Institute Foundation and is currently a member of the Rutgers Cancer Institute Director’s Advisory Council.

The award was presented at a gala dinner on October 24th where they were recognized for leadership, generosity and dedication to improving human life.

In receiving this award, Mignon and inVentiv join the ranks of a number of distinguished individual and corporate winners including Johnson & Johnson and Unilever, New Jersey Governor Christine Todd Whitman and John R. Whitman and Mary Lasser and the Thomas A Lasser Foundation.

About inVentiv Health
inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to the life sciences industry. inVentiv offers convergent services that accelerate the performance of companies working to improve human life. In 40 countries around the world, inVentiv’s 12,000 employees work with more than 550 pharmaceutical, biotech and device companies, as well as companies that see health as a central part of their mission. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings, Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. inVentiv Health helps clients transform promising ideas into commercial reality. For more information, visit

To learn more about how inVentiv Health experts can help you, please contact us by clicking here.

Contact Us

inVentiv Health has been made aware of an internet scam targeting job seekers who have posted their resumes on job posting websites. Scammers are contacting applicants via email and purporting to represent inVentiv Health. Many of these scammers are using Gmail accounts and Google Hangouts to communicate with applicants. All correspondence with us comes from an internal employee with a valid email address. Anyone who suspects they have been solicited in this scam should contact the FBI at